Trademark: 75713772
Status Date
Saturday, March 7, 2009
Registration Number
2576473
Registration Date
Tuesday, June 4, 2002
Filing Date
Tuesday, May 25, 1999
Published for Opposition
Tuesday, August 8, 2000
Cancellation Date
Saturday, March 7, 2009
5 pharmaceutical preparations, namely, recombinant adeno-associated virus expressing factor IX, for the treatment of hemophilia
Mar 7, 2009
Cancelled Sec. 8 (6-Yr)
Sep 6, 2007
Case File In Ticrs
Sep 14, 2006
Attorney Revoked And/Or Appointed
Sep 14, 2006
Teas Revoke/Appoint Attorney Received
Sep 14, 2006
Attorney Revoked And/Or Appointed
Sep 14, 2006
Teas Revoke/Appoint Attorney Received
Sep 14, 2006
Teas Change Of Correspondence Received
Jun 4, 2002
Registered-Principal Register
Nov 19, 2001
Allowed Principal Register - Sou Accepted
Nov 9, 2001
Assigned To Examiner
Oct 26, 2001
Statement Of Use Processing Complete
Oct 26, 2001
Use Amendment Filed
Apr 26, 2001
Extension 1 Granted
Mar 29, 2001
Extension 1 Filed
Oct 31, 2000
Noa Mailed - Sou Required From Applicant
Aug 8, 2000
Published For Opposition
Jul 7, 2000
Notice Of Publication
Apr 12, 2000
Approved For Pub - Principal Register
Jan 18, 2000
Correspondence Received In Law Office
Apr 4, 2000
Assigned To Examiner
Oct 1, 1999
Non-Final Action Mailed
Sep 8, 1999
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
